KR Choksey's research report on Cipla
The consolidated revenue for the quarter grew by 9.1% YoY to INR 57,393 Mn (-1.3% QoQ) driven by good traction in the US markets. For FY23, the revenues stood at INR 2,27,531 Mn (+4.5% YoY). EBITDA for the quarter stood at INR 11,737 Mn, contracted by 16.6% on QoQ ( +21% YoY). The EBITDA margins declined by -378 bps on QoQ at 20.5% (+202bps YoY). The quarterly margins reduced due to the high inflationary environment and rise in R&D spend. However, the company reported highest ever EBITDA of INR 50270 Mn in FY23 . The EBITDA margins for FY23 stood at 22.1%. PAT for the quarter declined by 18.5% YoY and 35.4% QoQ to INR 5215 Mn. The PAT margins stood at 9.1% ( -307 bps YoY, -482 bps QoQ) . EPS for the quarter stood at INR 6.47 as against INR 8.80 in FY22 and INR 10.02 in Q4FY22.
Outlook
We have revised our target price to INR 1167/share (Earlier 1289), gives an upside potential of 26.5% from its CMP of INR 922/share, we revised our rating from ACCUMULATE to BUY rating on the shares of Cipla.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.